5328902025-10-012025-12-315328902025-04-012025-12-315328902025-10-012025-12-31in-capmkt:OtherExpenses1Member5328902025-04-012025-12-31in-capmkt:OtherExpenses1Member5328902025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15328902025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532890TAKENOTLISTEDINE142I01023Take Solutions LimitedMain BoardEquity2025-04-012026-03-312026-02-142026-02-06INRLakhsQuarterlyThird quarterSingle segment Life Sciences2026-02-1419:00:002026-02-1422:15:00Not applicable2025-10-012025-12-31UnauditedConsolidated0146140001461400000013530009000200002141000352300011091000011091000000011091000000011091000011091000000014793400010.070.07000.070.07Notes: <BR> <BR> 1. The Un-Audited Standalone and Consolidated Financial Statement for the quarter and nine months ended on December 31, 2025 has been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on February 14, 2026. <BR> <BR> 2. The Statutory Auditors of the Company have carried out Limited Review of the financial results for the quarter and nine months period ended on December, 31, 2025 in compliance with terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. <BR> <BR> 3. The statement has been prepared in accordance with the Companies (Indian Accounting Standard) Rules, 2015 (Ind AS) prescribed under section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. <BR> <BR> 4. Previous period figures have been re-grouped and re-classified wherever necessary. <BR> <BR> 5. As the Company's business activity falls within a single primary business segment, the disclosure requirements as per Ind-AS 108 "operating segments” are not applicable. <BR> <BR> 6. With effect from 31st December 2025, the Financial Results presentation is changed from “Millions to Lakhs”. <BR> 2025-04-012025-12-31UnauditedConsolidated0147010001470100000040670003485000610002263700030250000-155490000-155490001602000016020000-17151000659300000659300000487790001000004887900000001479340001-0.12-0.120.450.450.330.33Other Expenses2141000Other Expenses22637000Amount of items that will not be reclassified to profit or loss00Amount of items that will not be reclassified to profit or loss10000010000000000100000